Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
English HTA Finally Greenlights Conditional Funding for MSD’s Welireg
Sep 05 2024
•
By
Francesca Bruce
Despite positive recommendations, MSD maintains Welireg should have been subject to NICE's appraisal process for very rare disease treatments • Source: Shutterstock
More from United Kingdom
More from Europe